logo

For the Inventor, By the Inventor

Sparta, NJ, United States of America

Dario Doller

This inventor holds 11 USPTO granted patents and 7 published patent applications and 6 EPO patents. Top assignees: H. Lundbeck A/s, Concert Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dario Doller. Retrieved from https://idiyas.com/inventor/dario-doller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 18.2

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal9 out of 513 
 
H. Lundbeck A/s
 patents
silverMedal1 out of 136 
 
Concert Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 156 
 
Sun Pharmaceutical Industries Limited
 patents

Years Active: 2011-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 12029712 - Deuterated analogs of D-serine and uses thereof (2024-07-09),
2. 10668036 - Deuterated analogs of D-serine and uses thereof (2020-06-02),
3. 9656975 - Bicyclo[3.2.1]octyl amide derivatives and uses of same (2017-05-23),
4. 9359297 - Spirolactam derivatives and uses of same (2016-06-07),
5. 9212165 - Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same (2015-12-15),
6. 8921370 - Bicyclo[3.2.1]octyl amide derivatives and uses of same (2014-12-30),
7. 8716284 - Adamantyl diamide derivatives and uses of same (2014-05-06),
8. 8633190 - Spirolactam derivatives and uses of same (2014-01-21),
9. 8389519 - Adamantyl diamide derivatives and uses of same (2013-03-05),
10. 8198275 - Adamantyl diamide derivatives and uses of same (2012-06-12),
11. 7947680 - Adamantyl diamide derivatives and uses of same (2011-05-24),

Title: The Innovative Journey of Dario Doller

Introduction

Dario Doller, a prominent inventor based in Sparta, NJ, has made significant contributions to the field of pharmaceuticals with a focus on deuterated compounds. With a portfolio of 11 patents, Doller’s work is characterized by innovation and a commitment to advancing scientific knowledge.

Latest Patents

Among his latest patents, one notable disclosure revolves around "Deuterated analogs of D-serine and uses thereof." This innovative work relates to deuterated D-serine, including pharmaceutically acceptable salts, analogs, prodrugs, and pharmaceutical compositions, along with the methods of their use. This specific invention holds potential applications in enhancing therapeutic strategies.

Career Highlights

Throughout his career, Dario Doller has collaborated with reputable companies such as H. Lundbeck A/S and Concert Pharmaceuticals, Inc. His expertise in developing pharmaceutical solutions has established him as a thought leader in his domain.

Collaborations

In his journey, Doller has had the pleasure of working alongside talented individuals including Guiying Li and Gil Ma. These collaborations have likely fueled the creativity and innovation behind his noteworthy patents.

Conclusion

Dario Doller's contributions to the field of pharmaceuticals through his inventions and patents play a vital role in advancing therapeutic options. His dedication to innovation continues to influence the industry and inspire future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…